from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
Petition DENIED. Justice Alito took no part in the consideration or decision of this petition.
Reply of petitioners Mylan Pharmaceuticals, et al. filed. (Distributed)
Brief of respondents Acorda Therapeutics, Inc. and Alkermes Pharma Ireland Limited in opposition filed.
Brief of respondent AstraZeneca AB in opposition filed.
Brief amicus curiae of Generic Pharmaceutical Association filed.
Order extending time to file response to petition to and including November 21, 2016, for all respondents.
Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for the respondents Acorda Therapeutics, Inc., and Pharma Ireland Limited.
Petition for a writ of certiorari filed. (Response due October 21, 2016)
Mylan Pharmaceuticals, et al., Petitioner, represented by Roy T. Englert, Jr.
Acorda Therapeutics, Inc. and Alkermes Pharma Ireland Limited, Respondent, represented by Theodore B. Olson
AstraZeneca AB, Respondent, represented by Kannon K. Shanmugam
Generic Pharmaceutical Association, Amicus Curiae, represented by James H. Wallace Jr.